<Disease><Name>CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIm (SLC35A2-CDG)</Name><Synonym>CDG2M; SLC35A2-CDG</Synonym><OMIM><Number>300896</Number><URL>http://omim.org/entry/300896</URL></OMIM><Orphanet><Number>356961</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=356961</URL></Orphanet><Protein><Number>UDP-galactose translocator</Number><URL>http://www.uniprot.org/uniprot/P78381</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>Xp11.23</Gene><ICD>E77.8</ICD><Summary>very rare;X-linked dominant;Somatic mosaicism (males);mutation in the SLC35A2 gene</Summary><Symptoms><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3336</id><symptom>inverted nipples</symptom><category>BODY</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>6623</id><title>SLC35A2-CDG: Functional Characterization, Expanded Molecular, Clinical, and Biochemical Phenotypes of 30 Unreported Individuals</title><author>Ng BG,</author><journal>Hum Mutat</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6686</id><title>Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients</title><author>Vals MA,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6431</id><title>SLC35A2-related congenital disorder of glycosylation: Defining the phenotype</title><author>Yates TM,</author><journal>Eur J Paediatr Neurol</journal><year>2018</year><book /><volume>22</volume><number>6</number><pages>1095-1102</pages><co_aut>et al.</co_aut></literature><literature><id>6624</id><title>Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report</title><author>Westenfield K,</author><journal>BMC Med Genet</journal><year>2018</year><book /><volume>19</volume><number>1</number><pages>100</pages><co_aut>et al.</co_aut></literature><literature><id>4210</id><title>An insight into the orphan nucleotide sugar transporter SLC35A4</title><author>Sosicka P,</author><journal>Biochim Biophys Acta</journal><year>2017</year><book /><volume>1864</volume><number>5</number><pages>825-838</pages><co_aut>et al.</co_aut></literature><literature><id>4211</id><title>A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy&lt;/</title><author>Kimizu T,</author><journal>Brain Dev</journal><year>2017</year><book /><volume>39</volume><number>3</number><pages>256-260</pages><co_aut>et al.</co_aut></literature><literature><id>4209</id><title>A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach</title><author>Doerre K,</author><journal>J Inherit Metab Dis</journal><year>2015</year><book /><volume>38</volume><number>5</number><pages>931-940</pages><co_aut>et al.</co_aut></literature><literature><id>4212</id><title>Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation</title><author>Ng BG,</author><journal>Am J Hum Genet</journal><year>2013</year><book /><volume>92</volume><number>4</number><pages>632-636</pages><co_aut>et al.</co_aut></literature><literature><id>4213</id><title>De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy</title><author>Kodera H,</author><journal>Hum Mutat</journal><year>2013</year><book /><volume>34</volume><number>12</number><pages>1708-1714</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>